Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Medtronic
Harvard Business School
McKinsey
Merck

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Huperzine A


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Huperzine A?

Huperzine A is an investigational drug.

There have been 13 clinical trials for Huperzine A. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.

The most common disease conditions in clinical trials are Alzheimer Disease, Cognitive Dysfunction, and Cognition Disorders. The leading clinical trial sponsors are Supernus Pharmaceuticals, Inc., Biscayne Neurotherapeutics, Inc., and Alzheimer's Disease Cooperative Study (ADCS).

Recent Clinical Trials for Huperzine A
TitleSponsorPhase
Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult SubjectsSupernus Pharmaceuticals, Inc.Early Phase 1
Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral HemorrhageJiangsu Famous Medical Technology Co., Ltd.Phase 4
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque ImagingShanghai Mental Health CenterPhase 4

See all Huperzine A clinical trials

Clinical Trial Summary for Huperzine A

Top disease conditions for Huperzine A
Top clinical trial sponsors for Huperzine A

See all Huperzine A clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Medtronic
Harvard Business School
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.